CYP8B1 Gene

Cytochrome P450 Family 8 Subfamily B Member 1

Gene Information Card

Symbol CYP8B1
Full Name Cytochrome P450 Family 8 Subfamily B Member 1
Gene Type Protein coding
Chromosomal Location 3p22.1
NCBI Gene ID 1582 ncbi.nlm.nih.gov/gene/1582
Ensembl ID ENSG00000163631
UniProt ID Q9UNU6
OMIM ID 602172
HGNC ID 2648
Aliases CP8B, CYP12, sterol 12-alpha-hydroxylase

Description

CYP8B1 encodes a member of the cytochrome P450 superfamily of enzymes, specifically sterol 12α-hydroxylase. This enzyme catalyzes the 12α-hydroxylation of 7α-hydroxy-4-cholesten-3-one, a critical step in the synthesis of cholic acid, the primary bile acid in humans. CYP8B1 activity determines the ratio of cholic acid to chenodeoxycholic acid in bile, influencing cholesterol homeostasis and bile acid pool composition. The gene is predominantly expressed in the liver and regulated by bile acid feedback via the FXR-SHP pathway.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cholestasis, progressive familial intrahepatic 1 Reduced CYP8B1 activity alters bile acid composition, contributing to cholestatic liver injury PMID: 23541340
Gallstone disease Altered cholic acid/chenodeoxycholic acid ratio promotes cholesterol supersaturation in bile PMID: 17661428
Hypertriglyceridemia CYP8B1 deficiency may affect lipid metabolism via altered bile acid signaling PMID: 21518877

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 32.5 High
Small intestine 1.2 Low
Kidney 0.8 Low
Adrenal gland 0.5 Not detected
Cell Line Expression
Cell Line nTPM Notes
HepG2 15.3 Hepatocellular carcinoma cell line
Huh-7 12.8 Hepatoma cell line
Primary hepatocytes 28.1 Normal liver cells
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) Missense <0.01% Loss of start codon, likely loss of function
c.334C>T (p.Arg112Trp) Missense <0.01% Reduced enzyme activity in vitro
c.1072G>A (p.Gly358Ser) Missense <0.01% Unknown functional effect
Mutation functional classification

Loss of Function (LOF)

Mutations affecting the start codon or catalytic residues (e.g., p.Met1?) are predicted to abolish enzyme activity, leading to altered bile acid composition.

Gain of Function (GOF)

No gain-of-function mutations have been reported for CYP8B1.

Dominant Negative (DN)

No dominant-negative mutations have been described for CYP8B1.

Gene Ontology (GO)

• sterol 12-alpha-hydroxylase activity • iron ion binding
• heme binding • oxidoreductase activity
• acting on paired donors • with incorporation or reduction of molecular oxygen
• bile acid biosynthetic process • cholesterol homeostasis

Pathways

Bile acid biosynthesis (KEGG: hsa00120)
Metabolism of lipids and lipoproteins (Reactome: R-HSA-556833)

Protein Summary

CYP8B1 is a 500-amino acid microsomal cytochrome P450 enzyme (UniProt Q9UNU6) localized to the endoplasmic reticulum in hepatocytes. It catalyzes the 12α-hydroxylation of 7α-hydroxy-4-cholesten-3-one to form 7α,12α-dihydroxy-4-cholesten-3-one, a committed step in cholic acid synthesis. The enzyme contains a conserved heme-binding domain and requires NADPH-cytochrome P450 reductase for activity. Its expression is tightly regulated by bile acid receptor FXR via SHP-mediated repression.

Related Products

Product name Cat.No. Species Gene ID
CYP8B1 Knockout HEK293 Cell Line EDJ-KQ4411 Human 1582 Details Get a Quote
CYP8B1 Knockout HeLa Cell Line EDJ-KQ53057 Human 1582 Details Get a Quote
CYP8B1 Knockout A-549 Cell Line EDJ-KQ61522 Human 1582 Details Get a Quote
CYP8B1 Knockout HCT 116 Cell Line EDJ-KQ70014 Human 1582 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: